Debates on the ethics of provision and cost of anti-retroviral drugs, particularly in poorer countries, have highlighted inequalities in healthcare and stimulated far-reaching legislative changes.
Aidsiravimite manustamiseetika ja -hinna arutelud on eriti vaesemates riikides toonud esile ebavõrdsuse tervisehoius ja põhjustanud seadusemuudatusi.